# PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer

> **NCT07691697** · — · RECRUITING · sponsor: **Affidea Nu-med Center of Oncological DIagnostics and Therapy** · enrollment: 1000 (estimated)

## Conditions studied

- Oligoprogressive Prostate Cancer
- Metastatic Prostate Cancer

## Interventions

- **RADIATION:** Comprehensive Progression-Directed Radiotherapy

## Key facts

- **NCT ID:** NCT07691697
- **Lead sponsor:** Affidea Nu-med Center of Oncological DIagnostics and Therapy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-26
- **Primary completion:** 2030-12-30
- **Final completion:** 2031-12-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07691697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07691697, "PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07691697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*